Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycohydrolases are a broad class of enzymes that catalyze the hydrolysis of glycosidic bonds in carbohydrates, glycoproteins, glycolipids, and related molecules. They play essential roles in various biological processes by breaking down complex sugars or sugar-containing structures. Key examples include Poly(ADP-ribose) Glycohydrolase (PARG), which regulates cellular processes such as DNA repair and cell death, and NAD+ Glycohydrolase, which participates in nicotinate/nicotinamide metabolism and calcium signaling. PARG is a therapeutic target for inflammation, ischemia-reperfusion injury, stroke, and cancer.
Inhibition of glycohydrolase activity, specifically PARG, to modulate DNA damage response and cell death pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycohydrolase.